Investing The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial November 27, 2024 Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Black Mountain Phase 2 Program has Commenced November 27, 2024 Next Post Investor Presentation Annual General Meeting November 27, 2024 Related Posts Sun Summit Announces Upsized Non-Brokered Private Placement of up to $11.5 Million December 13, 2025 Top 5 Canadian Mining Stocks This Week: Sirios Resources Gains 120 Percent December 13, 2025 Contango ORE, Dolly Varden Announce Strategic Silver Merger December 13, 2025
